Search

Displaying results 5501 - 5510 of 10000 in total
  1. Drug

    Pleospora betae

    go.drugbank.com/drugs/DB10936
    Approved

    Pleospora betae is a fungus which can provoke allergic reactions. Pleospora betae extract is used in allergenic testing.

  2. Drug

    Trichophyton tonsurans

    go.drugbank.com/drugs/DB10970
    Approved

    Trichophyton tonsurans is a fungus which can provoke allergic reactions. Trichophyton tonsurans extract is used in allergenic testing.

  3. Drug

    Trichophyton verrucosum

    go.drugbank.com/drugs/DB11295
    Approved

    Trichophyton verrucosum is a fungus which can provoke allergic reactions. Trichophyton verrucosum extract is used in allergenic testing.

  4. Drug

    Palmitic Acid

    go.drugbank.com/drugs/DB03796
    ApprovedInvestigational

    A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids.

    Mixtures: Huile D'onagre Vitamin E
  5. Drug

    AMG 108

    go.drugbank.com/drugs/DB05545
    Investigational

    AMG 108 was investigated for use as an antirheumatic agent.

  6. Drug

    TG100-115

    go.drugbank.com/drugs/DB05552
    Investigational

    An NSAID that inhibits PI-3K gamma and delta.

  7. Drug

    MD05

    go.drugbank.com/drugs/DB06375
    Investigational

    MD05 is a beta-tricalcium phosphate (beta-TCP) coated with recombinant human growth/differentiation factor-5 (rhGDF-5).

  8. Drug

    Cediranib

    go.drugbank.com/drugs/DB04849
    Investigational

    The novel indole-ether quinazoline Cediranib is a highly potent (IC<sub>50</sub> &lt; 1 nmol/L) ATP-competitive inhibitor of recombinant KDR tyrosine kinase in vitro. … It is being developed clinically as a once-daily oral therapy for the treatment of cancer.

  9. Drug

    Rebastinib

    go.drugbank.com/drugs/DB13005
    Investigational

    Rebastinib has been used in trials studying the treatment of Chronic Myeloid Leukemia. It is an inhibitor of Tie2 tyrosine kinase receptor and an antineoplastic agent.

  10. Drug

    Davalintide

    go.drugbank.com/drugs/DB14956
    Investigational

    Davalintide is under investigation in clinical trial NCT00785408 (Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects).